http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100852415-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-50 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K4-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00 |
| filingDate | 2004-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100852415-B1 |
| titleOfInvention | Polypeptides and derivatives thereof comprising novel heparin-binding sites derived from human tenacin-C |
| abstract | The present invention relates to a polypeptide comprising a novel heparin-binding site derived from human tenacin-C (TN) and derivatives thereof, and specifically, heparan sulfate proteoglycan (heparan sulfate). proteoglycan (HSPG) binding site and increases HSPG-dependent cell adhesion activity to tenasin-C type III domain 5 (TNIII5), including a part of the amino acid sequence of tenasin-C type III domain 4 (TNIII4) The present invention relates to a polypeptide and a derivative thereof. The polypeptide of the present invention can be usefully used as a cell adhesion peptide because it binds with heparin with high affinity and enhances cell adhesion. |
| priorityDate | 2004-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.